Endocrine Peptide Test Global Market Report 2025

Description

The endocrine peptide test is a diagnostic procedure used to assess levels of specific peptides in blood or urine, crucial for monitoring the endocrine system's function and detecting related disorders. It primarily focuses on measuring peptide hormones in blood to diagnose and track endocrine disorders.

Key tests in the endocrine peptide market include dehydroepiandrosterone sulfate (DHEAS), progesterone, luteinizing hormone, thyroid prolactin, estradiol, human chorionic gonadotropin, thyroid-stimulating hormone, among others. The DHEAS test specifically measures DHEAS levels in the bloodstream. Technologies employed include mass spectroscopy, immunoassay, chromatography, nucleic acid-based methods, and others. End users include clinics, healthcare centers, hospitals, and commercial laboratories.

The endocrine peptide test market research report is one of a series of new reports from The Business Research Company that provides endocrine peptide test market statistics, including the endocrine peptide test industry global market size, regional shares, competitors with endocrine peptide test market share, detailed endocrine peptide test market segments, market trends, and opportunities, and any further data you may need to thrive in the endocrine peptide test industry. These endocrine peptide test market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to $9.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing government spending, rising prevalence of diabetes, decreasing level of immunity in people across the world, high risk of contracting any chronic diseases, and rising government initiatives.

The endocrine peptide test market size is expected to see strong growth in the next few years. It will grow to $14.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for endocrine peptide test, growth in research and development activities, rise in number of lifestyle diseases, increasing geriatric population, and rising prevalence of diabetes amongst the masses. Major trends in the forecast period include advancement in the endocrine testing method, advancements in product technologies, increasing research and development activities to develop novel testing solutions, growing number of product approval, and shift towards preventive healthcare.

The growing prevalence of diabetes is expected to drive the expansion of the endocrine peptide test market. Diabetes refers to a range of conditions characterized by elevated blood sugar (glucose) levels. The rise in diabetes cases is attributed to factors such as poor diets, sedentary lifestyles, genetic factors, and an aging population. Endocrine peptide tests, including hemoglobin A1c, fasting plasma glucose, and C-peptide tests, are used to diagnose diabetes, monitor glucose levels, and evaluate insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS), a UK-based government agency, reported a notable increase in the number of individuals under 40 diagnosed with diabetes, rising from 173,166 in 2022 to 216,440 in 2023. This significant increase highlights the concerning trend of rising diabetes cases among younger individuals. Therefore, the increasing prevalence of diabetes is fueling the growth of the endocrine peptide test market.

Leading companies in the endocrine peptide test market are advancing immunoassay testing systems to enhance accuracy, sensitivity, and speed. These systems employ antibodies to detect and quantify specific peptides in blood or urine samples, providing healthcare professionals with essential insights into hormone levels and endocrine function. For example, Siemens Healthineers introduced the Atellica CI Analyzer in July 2023, a compact system capable of immunoassay and clinical chemistry testing, including endocrine peptide assays. It features a reproductive endocrinology menu with tests such as anti-Mullerian hormone (AMH) for ovarian reserve assessment and sFlt-1 and PlGF for preeclampsia prognosis. With a capacity of up to 1000 tests per hour, the Atellica CI Analyzer ensures rapid and consistent delivery of high-quality results, supporting laboratories in meeting evolving testing demands.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics to bolster its portfolio in pediatric endocrinology and men's health. Jatenzo, a testosterone replacement therapy, complements Tolmar's specialty pharmaceutical products, enhancing their offerings for individuals with endocrine disorders. Clarus Therapeutics, known for developing therapies in this field, facilitated the acquisition, expanding Tolmar's market presence and therapeutic capabilities.

Major companies operating in the endocrine peptide test market are Siemens AG, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Sciex, Bio-Techne Corporation, Invitae Corporation, ARUP Laboratories, Genova Diagnostics, Boston Heart Diagnostics Corporation, Immunodiagnostic Systems Ltd., Mayo Clinic Laboratories

North America was the largest region in the endocrine peptide test market in 2024. The regions covered in the endocrine peptide test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine peptide test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine peptide test market includes revenues earned by entities by providing services such as diagnostic testing, laboratory analysis, research studies, and clinical evaluations. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine peptide test market also includes sales of diagnostic kits, reagents, testing instruments, and laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Peptide Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine peptide test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine peptide test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine peptide test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Test-Type: Dehydroepiandrosterone Sulphate; Progesterone; Luteinizing Hormone; Thyroid Prolactin; Oestradiol; Human Chorionic Gonadotropin; Thyroid-Stimulating Hormone; Other Test-Types
2) By Technology: Mass Spectroscopy; Immunoassay; Chromatography; Nucleic Acid Based; Other Technologies
3) By End-User: Clinics; Healthcare Centers; Hospitals; Commercial Laboratories
Subsegments:
1) By Dehydroepiandrosterone Sulphate (DHEA-S): Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
2) By Progesterone: Immunoassay Tests; Chemiluminescence Assays; ELISA Tests
3) By Luteinizing Hormone (LH): Immunoassay Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (RIA)
4) By Thyroid Prolactin: Immunoassay Tests; Chemiluminescence Assays; Radioimmunoassay (RIA)
5) By Oestradiol: Immunoassay Tests; Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
6) By Human Chorionic Gonadotropin (hCG): Immunoassay Tests; Chemiluminescence Assays; Enzyme Immunoassay (EIA)
7) By Thyroid-Stimulating Hormone (TSH): Immunoassay Tests; Radioimmunoassay (RIA); Enzyme-Linked Immunosorbent Assay (ELISA)
8) Other Test-Types: Cortisol; Insulin; Growth Hormone (GH); Parathyroid Hormone (PTH)
Companies Mentioned: Siemens AG; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Merck KGaA; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30135

1. Executive Summary

2. Endocrine Peptide Test Market Characteristics

3. Endocrine Peptide Test Market Trends And Strategies

4. Endocrine Peptide Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Peptide Test Growth Analysis And Strategic Analysis Framework

5.1. Global Endocrine Peptide Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Endocrine Peptide Test Market Growth Rate Analysis
5.4. Global Endocrine Peptide Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Endocrine Peptide Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Endocrine Peptide Test Total Addressable Market (TAM)

6. Endocrine Peptide Test Market Segmentation

6.1. Global Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dehydroepiandrosterone Sulphate
Progesterone
Luteinizing Hormone
Thyroid Prolactin
Oestradiol
Human Chorionic Gonadotropin
Thyroid-Stimulating Hormone
Other Test-Types
6.2. Global Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Spectroscopy
Immunoassay
Chromatography
Nucleic Acid Based
Other Technologies
6.3. Global Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Healthcare Centers
Hospitals
Commercial Laboratories
6.4. Global Endocrine Peptide Test Market, Sub-Segmentation Of Dehydroepiandrosterone Sulphate (DHEA-S), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Enzyme-Linked Immunosorbent Assay (ELISA)
Radioimmunoassay (RIA)
6.5. Global Endocrine Peptide Test Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Chemiluminescence Assays
ELISA Tests
6.6. Global Endocrine Peptide Test Market, Sub-Segmentation Of Luteinizing Hormone (LH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Enzyme Immunoassay (EIA)
Radioimmunoassay (RIA)
6.7. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid Prolactin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Chemiluminescence Assays
Radioimmunoassay (RIA)
6.8. Global Endocrine Peptide Test Market, Sub-Segmentation Of Oestradiol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Enzyme-Linked Immunosorbent Assay (ELISA)
Radioimmunoassay (RIA)
6.9. Global Endocrine Peptide Test Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Chemiluminescence Assays
Enzyme Immunoassay (EIA)
6.10. Global Endocrine Peptide Test Market, Sub-Segmentation Of Thyroid-Stimulating Hormone (TSH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassay Tests
Radioimmunoassay (RIA)
Enzyme-Linked Immunosorbent Assay (ELISA)
6.11. Global Endocrine Peptide Test Market, Sub-Segmentation Of Other Test-Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cortisol
Insulin
Growth Hormone (GH)
Parathyroid Hormone (PTH)

7. Endocrine Peptide Test Market Regional And Country Analysis

7.1. Global Endocrine Peptide Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Endocrine Peptide Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Peptide Test Market

8.1. Asia-Pacific Endocrine Peptide Test Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Peptide Test Market

9.1. China Endocrine Peptide Test Market Overview
9.2. China Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Peptide Test Market

10.1. India Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Peptide Test Market

11.1. Japan Endocrine Peptide Test Market Overview
11.2. Japan Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Peptide Test Market

12.1. Australia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Peptide Test Market

13.1. Indonesia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Peptide Test Market

14.1. South Korea Endocrine Peptide Test Market Overview
14.2. South Korea Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Peptide Test Market

15.1. Western Europe Endocrine Peptide Test Market Overview
15.2. Western Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Peptide Test Market

16.1. UK Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Peptide Test Market

17.1. Germany Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Peptide Test Market

18.1. France Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Peptide Test Market

19.1. Italy Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Peptide Test Market

20.1. Spain Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Peptide Test Market

21.1. Eastern Europe Endocrine Peptide Test Market Overview
21.2. Eastern Europe Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Peptide Test Market

22.1. Russia Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Peptide Test Market

23.1. North America Endocrine Peptide Test Market Overview
23.2. North America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Peptide Test Market

24.1. USA Endocrine Peptide Test Market Overview
24.2. USA Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Peptide Test Market

25.1. Canada Endocrine Peptide Test Market Overview
25.2. Canada Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Peptide Test Market

26.1. South America Endocrine Peptide Test Market Overview
26.2. South America Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Peptide Test Market

27.1. Brazil Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Peptide Test Market

28.1. Middle East Endocrine Peptide Test Market Overview
28.2. Middle East Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Peptide Test Market

29.1. Africa Endocrine Peptide Test Market Overview
29.2. Africa Endocrine Peptide Test Market, Segmentation By Test-Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Endocrine Peptide Test Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Endocrine Peptide Test Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Peptide Test Market Competitive Landscape And Company Profiles

30.1. Endocrine Peptide Test Market Competitive Landscape
30.2. Endocrine Peptide Test Market Company Profiles
- 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Peptide Test Market Other Major And Innovative Companies

31.1. Laboratory Corporation of America Holdings (LabCorp)
31.2. Quest Diagnostics Incorporated
31.3. Agilent Technologies Inc.
31.4. Illumina Inc.
31.5. bioMerieux SA
31.6. Bio-Rad Laboratories Inc.
31.7. DiaSorin S.p.A.
31.8. Sciex
31.9. Bio-Techne Corporation
31.10. Invitae Corporation
31.11. ARUP Laboratories
31.12. Genova Diagnostics
31.13. Boston Heart Diagnostics Corporation
31.14. Immunodiagnostic Systems Ltd.
31.15. Mayo Clinic Laboratories

32. Global Endocrine Peptide Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Peptide Test Market

34. Recent Developments In The Endocrine Peptide Test Market

35. Endocrine Peptide Test Market High Potential Countries, Segments and Strategies

35.1 Endocrine Peptide Test Market In 2029 - Countries Offering Most New Opportunities
35.2 Endocrine Peptide Test Market In 2029 - Segments Offering Most New Opportunities
35.3 Endocrine Peptide Test Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer